Association between early risk factors and CDKN2A/B deletion in pediatric patients with acute lymphoblastic leukemia in a pediatric cancer center in Colombia
Authors:
- Cindy MartinezCMCindy Martinez
- Luz Karime YunisLYLuz Karime Yunis
- Edgar CabreraECEdgar Cabrera
- Johnny GarcíaJGJohnny García
- Gloria UribeGUGloria Uribe
- Edna QuinteroEQEdna Quintero
- Juan Jose YunisJYJuan Jose Yunis
- Adriana Linares BallesterosABAdriana Linares Ballesteros
- Isabel Cristina SarmientoISIsabel Cristina Sarmiento
Open Access
- 4 March 2022
- journal article
- Published by Elsevier in Pediatric Hematology Oncology Journal
- Vol. 7 (1) , 1-3
Abstract
No abstract availableKeywords
Funding Information
- Ministerio de Ciencia, Tecnología e Innovación (64342)
This publication has 6 references indexed in Scilit:
- The Yin and Yang-Like Clinical Implications of the CDKN2A/ARF/CDKN2B Gene Cluster in Acute Lymphoblastic LeukemiaGenes, 2021
- Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysisAnnals of Medicine, 2019
- Deletion of CDKN2A/B is associated with inferior relapse free survival in pediatric B cell acute lymphoblastic leukemiaLeukemia & Lymphoma, 2018
- Cyclin dependent kinase inhibitor 2A/B gene deletions are markers of poor prognosis in Indian children with acute lymphoblastic leukemiaPediatric Blood & Cancer, 2018
- The role of CDKN2A/B deletions in pediatric acute lymphoblastic leukemiaPediatric Hematology and Oncology, 2016
- Gene copy number alteration profile and its clinical correlation in B-cell acute lymphoblastic leukemiaLeukemia & Lymphoma, 2016